Trial Profile
A Pilot Study of Therapy With Pioglitazone Prior to HCV Treatment in HIV-1 and HCV Genotype 1-Infected Subjects With Insulin Resistance Who Are Prior Nonresponders to Peginterferon and Ribavirin Therapy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary) ; Peginterferon; Ribavirin
- Indications Hepatitis C; HIV infections
- Focus Therapeutic Use
- 19 Jan 2012 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.
- 19 Jan 2012 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.
- 19 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.